Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/1997
07/03/1997WO1997023501A1 Therapeutic compositions
07/03/1997WO1997023500A1 Endothelial cell proliferation inhibitor and method of use
07/03/1997WO1997023499A1 Prodrugs of thrombin inhibitors
07/03/1997WO1997023256A1 Localized intravascular delivery of growth factors for promotion of angiogenesis
07/03/1997WO1997023244A1 Use of antisene oligodeoxynucleotides to produce truncated proteins
07/03/1997WO1997023239A1 Dry compositions
07/03/1997WO1997023237A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
07/03/1997WO1997023236A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells
07/03/1997WO1997023235A1 Anti-lps factor from horseshoe crabs and methods of use
07/03/1997WO1997018238A3 Crf analogs
07/03/1997WO1997018232A3 Peptides derived from the oncogene proteine bcr-abl expressed by leukemic cells and utilisation thereof for the therapy of human leukemiae
07/03/1997WO1997016185A3 A pharmaceutical composition for the treatment of autoimmune diseases
07/03/1997DE19548367A1 Immunologisch wirksame Mistelextraktzubereitungen Immunologically effective mistletoe extract preparations
07/03/1997CA2241129A1 Therapeutic compositions
07/03/1997CA2241105A1 Staphylococcus aureus coenzyme a disulfide reductase, and inhibitors thereof useful as antimicrobial agents
07/03/1997CA2240941A1 Galactopyranosides and their use
07/03/1997CA2240834A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
07/03/1997CA2239909A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells
07/03/1997CA2239711A1 Compounds with growth hormone releasing properties
07/03/1997CA2239704A1 Polypeptides with interleukin 16 activity, process for the preparation and use thereof
07/03/1997CA2239682A1 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
07/03/1997CA2239303A1 Globins containing binding domains
07/03/1997CA2238737A1 Prodrugs of thrombin inhibitors
07/03/1997CA2237543A1 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
07/03/1997CA2213512A1 Method for producing bioactive fusion protein
07/02/1997EP0781847A1 Humanized monoclonal antibody
07/02/1997EP0781845A2 Anti-human milk fat globule humanised antibodies and processes for their production
07/02/1997EP0781844A1 Gene participating in apoptosis
07/02/1997EP0781779A2 Nonantigenic stabilizer and physiologically active substance
07/02/1997EP0781778A1 Novel paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy
07/02/1997EP0781560A1 Use of immunoglobulin preparations for the production of a drug for oral administration for treatment and prophylaxis of chronic pain conditions
07/02/1997EP0781558A2 Pharmaceutical use of heparin cofactor II
07/02/1997EP0781550A1 Bioadhesive pharmaceutical composition for the controlled release of active agents
07/02/1997EP0781436A1 System and method of automatically generating chemical compounds with desired properties
07/02/1997EP0781344A1 Novel implant and novel vector for the treatment of acquired diseases
07/02/1997EP0781338A1 VACCINES CONTAINING BORRELIA BURGDORFERI OspG
07/02/1997EP0781337A1 Humanised antibody to integrin chain beta-1
07/02/1997EP0781336A1 A human map kinase homolog
07/02/1997EP0781335A1 Cloning and characterizing of genes associated with long-term memory
07/02/1997EP0781334A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin
07/02/1997EP0781333A1 Gene therapy for transplantation and inflammatory or thrombotic conditions
07/02/1997EP0781331A1 Improvements in or relating to binding proteins for recognition of dna
07/02/1997EP0781326A1 The irs family of genes
07/02/1997EP0781297A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same
07/02/1997EP0781295A1 Asp b1 insulin analogs
07/02/1997EP0781294A1 Metal-containing ribonucleotide polypeptides
07/02/1997EP0781143A1 Method of blocking the sec receptor
07/02/1997EP0781142A1 Compositions and methods for delivery of polypeptides
07/02/1997EP0781141A1 Aza cyclohexapeptide compounds
07/02/1997EP0781140A1 Corticotropin release inhibiting factor and methods of using same
07/02/1997EP0781139A1 Intracellular delivery of chemical agents to a specific cell type
07/02/1997EP0781124A1 Active agent transport systems
07/02/1997EP0781095A1 Cells bearing cd4 decoy receptors and related molecules and methods
07/02/1997EP0781092A1 Method of sensitizing tumor cells with adenovirus e1a
07/02/1997EP0629347B1 Antibacterial agent and treatment of article therewith
07/02/1997EP0627000A4 Mammalian expression systems for hcv proteins.
07/02/1997EP0621871B1 A human kunitz-type protease inhibitor variant
07/02/1997EP0592692B1 Fed batch process for protein secreting cells
07/02/1997EP0544713B1 Oligonucleotides for modulating the effects of cytomegalovirus infections
07/02/1997CN1153529A Hepatitis G virus and molecular cloning thereof
07/02/1997CN1153528A Pantropic neurotrophic factors
07/02/1997CN1153477A Extracts of shark cartilage having anti-angiogenic activity and effect on tumor regression, process of making thereof
07/02/1997CN1153062A Human urinary trypsin inhibitor preparation and method for production thereof
07/01/1997USH1662 Chemically modified lymphokine and production thereof
07/01/1997US5644055 Cyclization of indole or quinoline compound, enzyme inhibitors, treatment of cardiovasacular disorders
07/01/1997US5644047 Compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection
07/01/1997US5644046 Cloning of a gene encoding for the growth hormone releasing hormone receptor
07/01/1997US5644045 X-linked adrenoleukodystrophy gene and corresponding protein
07/01/1997US5644036 Purified immunoglobulin
07/01/1997US5644035 Method for purifying secreted Mac-2-binding glycoprotein
07/01/1997US5644034 Tumour necrosis factor binding ligands
07/01/1997US5644033 Monoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatment
07/01/1997US5644031 Delta-like gene expressed in neuroendocrine tumors
07/01/1997US5644030 Gene and method for production of an IgA binding protein
07/01/1997US5644026 Antitumor agent polypeptides
07/01/1997US5644025 Tetrapeptides deriving from dalbaheptide antibiotics
07/01/1997US5644024 Tetrahydronaphthalene derivatives
07/01/1997US5643957 Compounds and compositions for delivering active agents
07/01/1997US5643949 Cosmetic composition for hair and skin disorders in humans
07/01/1997US5643924 Retroviral protease inhibitors
07/01/1997US5643904 Treating pain, ulcers, collitis, anxiety and panic disorder
07/01/1997US5643891 Treatment of viral infections
07/01/1997US5643890 Anticarcinogenic agents
07/01/1997US5643881 Protein having anti-HIV activity and method for obtaining it
07/01/1997US5643880 Casein isolated from milk and joining to oropharyngeal cells
07/01/1997US5643879 Oligopeptide enzyme inhibitors as hypotensive agents
07/01/1997US5643878 Treatment of retroviral diseases like aids
07/01/1997US5643877 Compounds comprising gonadotropin releasing hormone (GnRH) and methods for controlling reproduction in fish
07/01/1997US5643876 Biologically active synthetic magainin peptides
07/01/1997US5643875 Proteins and endotoxins
07/01/1997US5643873 Antiinflammatory
07/01/1997US5643872 Antiagglomerants for platelets, anticoagulants
07/01/1997US5643871 Antitumor antibiotics
07/01/1997US5643870 Topical asthma treatment
07/01/1997US5643869 Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them
07/01/1997US5643868 Method of treating or preventing type 1 diabetes by oral administration of insulin
07/01/1997US5643867 Method for treating catabolic conditions
07/01/1997US5643786 Method for isolating dendritic cells
07/01/1997US5643785 Polynucleotides encoding AMPA-binding human GluR4 receptors
07/01/1997US5643781 DNA encoding protocadherin-42